| Indicators | Browse All

Certara, Inc. (CERT)

Healthcare | Health Information Services | Radnor, United States | NasdaqGS
9.60 USD +0.36 (3.896%) ⇧ (Oct. 13, 2026, 4 p.m. EDT)

Short-term:★★⯪☆☆Long-term:★★⯪☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 6:03 a.m. EDT

The investment case for Certara remains fractured by a severe disconnect between its operational reality and its market valuation. While the company recently posted a modest revenue increase (+2.4%), the stock has been punished over the last four years, dropping nearly 65% from its peak. This multi-year decline suggests the market views the recent top-line growth as insufficient to offset persistent operational inefficiencies, evidenced by negative operating margins and a return on equity that remains in the negative territory. The balance sheet is fragile, carrying debt levels that exceed equity, which limits the flexibility to fund the aggressive expansion implied by the recent NVIDIA partnership news. From a trading perspective, the momentum is neutral-to-slightly-negative. The stock is hovering near its 200-day average, having failed to capitalize on the recent quarterly software highlights. The options market reflects this ambivalence: there is no significant gamma exposure or unusual flow driving a clear trend, just scattered bets on a bounce or a drop. With no dividend to provide income and a forward P/E that implies high expectations for earnings turnaround despite current losses, the risk-reward profile appears unattractive. The recent legal investigation headlines add a layer of uncertainty that likely keeps institutional capital on the sidelines. Until the company demonstrates sustained profitability and a clear path to de-leveraging, the 'value' here looks more like a value trap than a bargain.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.035392
AutoETS0.062293
AutoARIMA0.070713
AutoTheta0.079253

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 31%
H-stat 16.03
Ljung-Box p 0.000
Jarque-Bera p 0.673
Excess Kurtosis 0.22
Attribute Value
Sector Healthcare
Debt to Equity Ratio 31.241
Revenue per Share 2.67
Market Cap 1,464,372,352
Forward P/E 24.52
Beta 1.43
Profit Margins -16.22%
Website https://www.certara.com

As of Oct. 10, 2026, 6:03 a.m. EDT: Speculators are positioning for a range-bound outcome with a distinct lack of bullish conviction. Call open interest is heavily skewed toward out-of-the-money strikes (12.5), suggesting a speculative hope for a rebound to previous highs, while the bulk of call volume sits at the money. Conversely, put activity is concentrated in deep out-of-the-money strikes (5.0), indicating a hedge against a further decline rather than a bearish bet on a crash. The near-term expiration shows virtually zero put volume, implying traders are not hedging immediate downside risk, but the overall low volume and scattered positioning suggest a lack of a unified directional thesis.


Info Dump

Attribute Value
52 Week Change -0.2280702
Address1 4 Radnor Corporate Center
Address2 Suite 350
All Time High 45.48
All Time Low 4.45
Ask 11.9
Ask Size 2
Audit Risk 3
Average Analyst Rating 2.4 - Buy
Average Daily Volume10 Day 3,384,260
Average Daily Volume3 Month 3,096,946
Average Volume 3,096,946
Average Volume10Days 3,384,260
Beta 1.428
Bid 7.12
Bid Size 2
Board Risk 6
Book Value 6.338
City Radnor
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 4
Country United States
Crypto Tradeable 0
Currency USD
Current Price 9.6
Current Ratio 2.551
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 9.9
Day Low 9.26
Debt To Equity 31.241
Display Name Certara
Dividend Yield 0.0
Earnings Call Timestamp End 1,785,846,600
Earnings Call Timestamp Start 1,785,846,600
Earnings Timestamp 1,785,846,600
Earnings Timestamp End 1,793,881,800
Earnings Timestamp Start 1,793,881,800
Ebitda 94,250,000
Ebitda Margins 0.22348
Enterprise To Ebitda 16.779
Enterprise To Revenue 3.75
Enterprise Value 1,581,450,240
Eps Current Year 0.34004
Eps Forward 0.39147
Eps Trailing Twelve Months -0.14
Esg Populated 0
Exchange NMS
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 8.4298
Fifty Day Average Change 1.1702003
Fifty Day Average Change Percent 0.1388171
Fifty Two Week Change Percent -22.80702
Fifty Two Week High 12.94
Fifty Two Week High Change -3.3399992
Fifty Two Week High Change Percent -0.2581143
Fifty Two Week Low 4.45
Fifty Two Week Low Change 5.1500006
Fifty Two Week Low Change Percent 1.1573036
Fifty Two Week Range 4.45 - 12.94
Financial Currency USD
First Trade Date Milliseconds 1,607,697,000,000
Float Shares 111,952,787
Forward Eps 0.39147
Forward P E 24.522953
Free Cashflow 62,582,376
Full Exchange Name NasdaqGS
Full Time Employees 1,515
Fullday Change -0.10000038
Fullday Change Percent -1.0416706
Fullday Price 9.5
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,790,812,800
Gross Margins 0.61608005
Gross Profits 259,831,008
Has Pre Post Market Data 1
Held Percent Insiders 0.027290002
Held Percent Institutions 1.13423
Implied Shares Outstanding 152,538,780
Industry Health Information Services
Industry Disp Health Information Services
Industry Key health-information-services
Ipo Expected Date 2,020-12-11
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. It also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix cloud that offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration that supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform; Certara D360 software, a scientific informatics system; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and writes regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.
Long Name Certara, Inc.
Market us_market
Market Cap 1,464,372,352
Market State PRE
Max Age 86,400
Message Board Id finmb_100474847
Most Recent Quarter 1,782,777,600
Net Income To Common -22,502,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 1,314,121,589
Number Of Analyst Opinions 11
Open 9.3
Operating Cashflow 82,863,000
Operating Margins -0.0021
Overall Risk 6
Payout Ratio 0.0
Phone 415 237 8272
Pre Market Change -0.10000038
Pre Market Change Percent -1.0416706
Pre Market Price 9.5
Pre Market Time 1,791,967,647
Previous Close 9.24
Price Eps Current Year 28.231974
Price Hint 2
Price To Book 1.5146735
Price To Sales Trailing12 Months 3.4721668
Profit Margins -0.16219
Quick Ratio 2.441
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key buy
Recommendation Mean 2.38462
Region US
Regular Market Change 0.360001
Regular Market Change Percent 3.89611
Regular Market Day High 9.9
Regular Market Day Low 9.26
Regular Market Day Range 9.26 - 9.9
Regular Market Open 9.3
Regular Market Previous Close 9.24
Regular Market Price 9.6
Regular Market Time 1,791,921,601
Regular Market Volume 2,905,629
Return On Assets 0.00765
Return On Equity -0.022090001
Revenue Growth 0.01
Revenue Per Share 2.67
Sand P52 Week Change 0.17502642
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 8
Shares Outstanding 152,538,780
Shares Percent Shares Out 0.1816
Shares Short 27,704,005
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 28,972,317
Short Name Certara, Inc.
Short Percent Of Float 0.2845
Short Ratio 11.03
Source Interval 15
State PA
Symbol CERT
Target High Price 11.0
Target Low Price 7.0
Target Mean Price 8.89545
Target Median Price 9.0
Total Cash 184,867,008
Total Cash Per Share 1.212
Total Debt 301,944,992
Total Revenue 421,745,984
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.14
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 7.1925
Two Hundred Day Average Change 2.4075003
Two Hundred Day Average Change Percent 0.3347237
Type Disp Equity
Volume 2,905,629
Website https://www.certara.com
Zip 19,087